Form D · Pharmaceuticals
BridgeHealth Pharmaceuticals, Inc.
Woburn, MA · CIK 0002162724
Offering snapshot reported Nov 5, 2026 · SEC filing
- Reported sold
- $3.5M Offering amount: $3.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 22, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 5, 2026 | Initial | $3,500,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-603806
Amounts include conversion of outstanding convertible securities.
Source: Form D, filed Nov 5, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Howard Ackerman | Director |
| Neal Muni | Director, Executive |
| Indu Muni | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
400 Tradecenter Suite #5900
Woburn, MA, 01801
Woburn, MA, 01801